The lncRNA CASC19 is markedly upregulated and is associated with tumor progression and poorer prognoses in various cancers, including colorectal cancer, advanced gastric cancer, non-small lung cancer cells, and pancreatic cancer (43–46). Here, CASC19 is linked to pancreatic neoplasm.